Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties: Endocrinology

The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)

Gauri Khorjekar, Douglas Van Nostrand, Richard Vetter, Matthew Ringel, Elizabeth Carter and Gary Bloom
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1580;
Gauri Khorjekar
1Nucl Med, Wash Hosp Ctr, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas Van Nostrand
1Nucl Med, Wash Hosp Ctr, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Vetter
2Ohio State U, Columbus, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Ringel
3Mayo Clinic, Rochester, MN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Carter
4Medstar Res Inst, Hyattsville, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary Bloom
5ThyCa, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 51 no. supplement 2 1580

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
© 2010

Author Information

  1. Gauri Khorjekar1,
  2. Douglas Van Nostrand1,
  3. Richard Vetter2,
  4. Matthew Ringel3,
  5. Elizabeth Carter4 and
  6. Gary Bloom5
  1. 1Nucl Med, Wash Hosp Ctr, Washington, DC
  2. 2Ohio State U, Columbus, OH
  3. 3Mayo Clinic, Rochester, MN
  4. 4Medstar Res Inst, Hyattsville, MD
  5. 5ThyCa, Washington, DC

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: December 2014 to April 2025

AbstractFullPdf
Dec 2014100
Feb 2015200
Mar 2015400
May 2015700
Jun 2015400
Sep 2015600
Nov 2015500
Feb 2016800
Jun 2016100
Jul 2016400
Dec 2016300
Jan 2017200
Mar 2017300
Apr 2017300
Jun 2017100
Jul 2017100
Aug 2017100
Sep 2017100
Oct 2017400
Nov 2017200
Feb 2018100
Mar 2018300
Jun 2018100
Sep 2018400
Oct 2018500
Nov 2018100
Dec 2018100
Jan 2019100
Feb 2019300
Mar 2019200
Apr 2019100
May 2019400
Jun 20191100
Jul 2019200
Sep 2019100
Nov 2019200
Dec 2019100
Feb 2020200
Apr 2020100
May 2020100
Nov 2020100
Dec 2020400
Jan 2021500
Feb 20211900
Mar 20211700
Apr 20211700
May 20212500
Jun 20211400
Jul 20215100
Aug 20217400
Sep 20211500
Oct 2021800
Nov 2021500
Dec 2021800
Jan 2022800
Feb 20221000
Mar 2022900
Apr 2022600
May 20221000
Jun 20221100
Jul 20221400
Aug 20221500
Sep 2022800
Oct 20221600
Nov 20221100
Dec 20221100
Jan 20232100
Feb 20232100
Mar 20231500
Apr 20231500
May 20231500
Jun 20235500
Jul 20232300
Aug 20231800
Sep 20232700
Oct 20233000
Nov 20232900
Dec 20232300
Jan 20242900
Feb 20242600
Mar 20242900
Apr 20242500
May 20245300
Jun 20243400
Jul 20242400
Aug 20242400
Sep 20246800
Oct 20243300
Nov 20243300
Dec 20243100
Jan 20253100
Feb 20252500
Mar 20252800
Apr 20252800
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)
Gauri Khorjekar, Douglas Van Nostrand, Richard Vetter, Matthew Ringel, Elizabeth Carter, Gary Bloom
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1580;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)
Gauri Khorjekar, Douglas Van Nostrand, Richard Vetter, Matthew Ringel, Elizabeth Carter, Gary Bloom
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1580;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties: Endocrinology

  • A comparison of the psychological status in the patients with hyperthyroidism before and after treatment with radioiodine-131
  • The correlation between salivary gland uptake in pre- and post-ablative 131I whole body scan and late salivary gland side effect after initial radioactive iodine therapy
Show more General Clinical Specialties: Endocrinology

Endocrinology Posters

  • A comparison of the psychological status in the patients with hyperthyroidism before and after treatment with radioiodine-131
  • The correlation between salivary gland uptake in pre- and post-ablative 131I whole body scan and late salivary gland side effect after initial radioactive iodine therapy
  • Low dose I-123 MIBG diagnostic scan is inferior to I-131 MIBG post-treatment scan in detection of neuroblastoma
Show more Endocrinology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire